Overall, this work proves that BSJPD can prolong the survival of patients with liver cancer and promote hepatoma cell apoptosis, which is associated with its modulation of the PI3K-Akt-mTOR pathway and the p53, CASP3, and Bcl-xL/BAD proteins. The gene discussed is TP53; the disease is liver cancer.